共 50 条
- [41] Efficacy and safety of topically applied therapeutic ammonia oxidising bacteria in adults with mild-to-moderate atopic dermatitis and moderate-to-severe pruritus: a randomised, double-blind, placebo-controlled, dose-ranging, phase 2b trialECLINICALMEDICINE, 2023, 60Silverberg, Jonathan I.Lio, Peter A.Simpson, Eric L.Li, ConnieBrownell, Daniel R.Gryllos, IoannisNg-Cashin, JudithKrueger, ToddSwaidan, Victoria R.Bliss, Robin L.Kim, Hyun D.
- [42] KM110329 in adult patients with atopic dermatitis: a randomised, double-blind, placebo-controlled, multicentre trial - study protocolBMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 13Cheon, ChunhooPark, SunjuPark, Jeong-SuOh, So-MiJang, SoobinGo, Ho-YeonJang, Bo-HyoungShin, Yong-CheolKo, Seong-Gyu
- [43] Efficacy and safety of topical OPA-15406, a new phosphodiesterase 4 inhibitor, in Japanese patients with atopic dermatitis for 8 weeks: A phase 2, randomized, double-blind, placebo-controlled studyJOURNAL OF DERMATOLOGY, 2019, 46 (08) : 672 - 679Saeki, HidehisaKawashima, MakotoSugaya, SatokoOshiden, KazuhideTsubouchi, Hidetsugu
- [44] A randomized, double-blind study to assess the efficacy of addition of tetracycline to triamcinolone acetonide in the treatment of moderate to severe atopic dermatitisJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (09) : 1076 - 1082Schuttelaar, M. L. A.Coenraads, P. J.
- [45] Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitisJOURNAL OF DERMATOLOGY, 2015, 42 (02) : 129 - 139Murata, YokoSong, MichaelKikuchi, HisayukiHisamichi, KatsuyaXu, Xie L.Greenspan, AndrewKato, MaiChiou, Chiun-FangKato, TakeshiGuzzo, CynthiaThurmond, Robin L.Ohtsuki, MamitaroFurue, Masutaka
- [46] Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension studyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (04) : 1121 - +Kabashima, KenjiFurue, MasutakaHanifin, Jon M.Pulka, GrazynaWollenberg, AndreasGalus, RyszardEtoh, TakafumiMihara, RyosukeNakano, MiwaRuzicka, Thomas
- [47] ANTIOXIDANT SUPPLEMENT HAD A LOWER EFFECT OF ATOPIC DERMATITIS IN YOUNG CHILDREN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CLINICAL TRIALANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 1358 - 1358Oh, S. Y.Kwon, S. O.Park, H. S.Seo, J. W.Choi, H. Y.Chung, J. Y.
- [48] Efficacy and safety of So-Cheong-Ryong-Tang in patients with atopic dermatitis and respiratory disorders Study protocol of a double-blind randomized placebo-controlled trialMEDICINE, 2020, 99 (02)Kang, Su-JinCho, Han-BaekJo, Eun-HeuiYang, Geum-JinHong, Ji-EunLee, Ju-HyunShim, Yu-HwaMun, Jung-HyunPark, Min-Cheol
- [49] A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitisBRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (06) : 1282 - 1289Reitamo, SOrtonne, JPSand, CCambazard, FBieber, TFölster-Holst, RVena, GBos, JDFabbri, PLarsen, CG
- [50] Placebo-controlled, double-blind, randomized, prospective study of a glycerol-based emollient on eczematous skin in atopic dermatitis: Biophysical and clinical evaluationSKIN PHARMACOLOGY AND PHYSIOLOGY, 2008, 21 (01) : 39 - 45Breternitz, M.Kowatzki, D.Langenauer, M.Elsner, P.Fluhr, J. W.